The Board of Directors of Ho Wah Genting Berhad (“HWGB” or “Company”) wishes to announce that EBI had on even date informed the Company that, upon advise from FDA, EBI had on 22 June 2021 submitted its report on the total 300 subjects assessed in relation to immune responses for the prevention of COVID-19 following a booster dose of inactivated poliovirus (IPV) vaccine in adults to the FDA under the Emergency Use Authorisation (EUA) 不知道这结果会 怎样。。（没买卖建议）